Overview of KRAS and KRAS inhibitors in Oncology

This keynote will delve into the transformative journey of KRAS research in oncology, exploring its pivotal role in cancer biology, therapeutic targeting, and the evolution from 'undruggable' to actionable strategies. Key themes include the mechanisms of RAS signalling, mutation impacts, innovative inhibitor techniques, and overcoming therapeutic resistance. Leveraging historical breakthroughs and cutting-edge clinical trials, the presentation highlights next-generation therapies and their...